Supplementary Table S2 from Dissecting the Tumor Microenvironment to Identify Biomarkers of Outcome to Anti–PD-1 Therapy in Clear-Cell Renal Cell Carcinoma: Analyses of the HCRN GU16-260 Trial

Authors:
Open Access
Publisher website
Google Scholar
Abstract
Supplementary Table 2. List of the antibodies and dyes used for the Multiplex IF assay (panel 2).